Literature DB >> 8218997

Natural history of chronic hepatitis B virus infection: new light on an old story.

D S Chen1.   

Abstract

Chronic hepatitis B virus (HBV) infection is one of the most common persistent virus infection in man. It causes significant morbidity and mortality, and therefore is important. Extensive studies on clinicopathologic studies and long-term follow up on hepatitis B surface antigen (HBsAg) carriers have largely disclosed the natural history of chronic HBV infection. The infection easily becomes chronic when contracted in early infancy. As high as 90% of babies born to HBV carrier mothers will also become HBsAg carriers. Once chronic infection is established, it is refractory, and HBsAg carriage usually persists for life. However, the chronic infection is not monotonous, it actually evolves from an HBV replicative phase to a non-replicative phase. The host responds differently and with more complexity in different phases. The virus-host interactions, divided into three phases, virus tolerance, virus clearance and residual HBV integrated phases, result in a heterogeneous variety of hepatic lesions. The first two phases occur when HBV is actively replicating, and the last corresponds to the non-replicative phase. The high HBV level (and hence HBV gene products) renders the host's immune system tolerant to the virus, and the infected host does not exert an effort to get rid of the virus. At this stage, the liver is nearly normal, and the host is asymptomatic. However, later in the replicative phase, the HBV replication begins to wane, and the immune tolerance is no longer maintained.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8218997     DOI: 10.1111/j.1440-1746.1993.tb01551.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  21 in total

1.  Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B.

Authors:  Shoji Kubo; Kazuhiro Hirohashi; Osamu Yamazaki; Mitsuharu Matsuyama; Hiromu Tanaka; Katsuhiko Horii; Taichi Shuto; Takatsugu Yamamoto; Shuichi Kawai; Kenichi Wakasa; Shuhei Nishiguchi; Hiroaki Kinoshita
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

2.  Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients.

Authors:  Zhi-Tao Yang; Xin-Xin Zhang; Xiao-Fei Kong; Dong-Hua Zhang; Shen-Ying Zhang; Jie-Hong Jiang; Qi-Ming Gong; Gen-Di Jin; Zhi-Meng Lu
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 3.  What is expected from the pathologist in the diagnosis of viral hepatitis?

Authors:  Helmut Denk
Journal:  Virchows Arch       Date:  2011-02-26       Impact factor: 4.064

4.  New insights into the evolutionary rate of hepatitis B virus at different biological scales.

Authors:  You-Yu Lin; Chieh Liu; Wei-Hung Chien; Li-Ling Wu; Yong Tao; Dafei Wu; Xuemei Lu; Chia-Hung Hsieh; Pei-Jer Chen; Hurng-Yi Wang; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

5.  Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Authors:  Evangelista Sagnelli; Tommaso Stroffolini; Caterina Sagnelli; Mario Pirisi; Sergio Babudieri; Guido Colloredo; Maurizio Russello; Nicola Coppola; Giovanni Battista Gaeta; Bruno Cacopardo; Massimo De Luca; Piero Luigi Almasio
Journal:  Infection       Date:  2017-11-17       Impact factor: 3.553

Review 6.  To treat or not to treat the "immunotolerant phase" of hepatitis B infection: A tunnel of controversy.

Authors:  Mohamed A Mekky
Journal:  World J Hepatol       Date:  2014-04-27

7.  Role of viral factors in the natural course and therapy of chronic hepatitis B.

Authors:  Jia-Horng Kao
Journal:  Hepatol Int       Date:  2007-10-12       Impact factor: 6.047

8.  Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases.

Authors:  Hurng-Yi Wang; Ming-Hung Chien; Hsiang-Po Huang; Hsiao-Chi Chang; Chung-Che Wu; Pei-Jer Chen; Mei-Hwei Chang; Ding-Shinn Chen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

9.  Synergistic effect of hepatitis virus infection and occupational exposures to vinyl chloride monomer and ethylene dichloride on serum aminotransferase activity.

Authors:  H-I Hsieh; J-D Wang; P-C Chen; T-J Cheng
Journal:  Occup Environ Med       Date:  2003-10       Impact factor: 4.402

Review 10.  Viral hepatitis in children with renal disease.

Authors:  G V Gregorio; A P Mowat
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.